Clinical trials
Phase 1/2 Sarcoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2017 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essen Biotech | 2 |
| Fuda Cancer Hospital, Guangzhou | 2 |
| Shenzhen Geno-Immune Medical Institute | 2 |
| Haihe Biopharma Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| ImmVira Pharma Co. Ltd | 1 |
| Innolake Biopharm | 1 |
| Lyvgen Biopharma Holdings Limited | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 13 |
| Sarcoma, Ewing | 4 |
| Breast Neoplasms | 3 |
| Esophageal Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Bone Neoplasms | 2 |
| Carcinoma, Bronchogenic | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.